TrialPloS one2017

Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial.

David R Clemmons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.